Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin effects on IL-6 and IL-9 in coronary artery bypass graft surgery
IRCT20141009019470N72Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in coronary arteriosclerosis, sponsored by Shiraz University of Medical Sciences. Primary endpoints: Change in interleukin-6 (IL-6) levels and Change in interleukin-9 (IL-9) levels. Started Apr 2018; status: completed.
02
Drugs
melatonin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20141009019470N72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141009019470N72.